Month: April 2024

DURHAM, N.C., April 29, 2024 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the first quarter of fiscal year 2024 before the market opens on Tuesday, May 7, 2024. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update. To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call. A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company’s website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until May 6, 2025. About BioventusBioventus...

Long-term data and subgroup analyses from pivotal EYLEA HD clinical program continue to demonstrate durable efficacy and consistent safety in patients with wet age-related macular degeneration and certain diabetic eye diseases TARRYTOWN, N.Y., April 29, 2024 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the presentation of positive long-term results and subgroup analyses from the pivotal clinical program of EYLEA® HD (aflibercept) Injection 8 mg. The presentations are part of 14 accepted abstracts on EYLEA HD and EYLEA® (aflibercept) Injection 2 mg that will be shared at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting from May 5 to 9 in Seattle. “Our extensive data presentations at ARVO showcase the differentiated efficacy, safety and durability of EYLEA HD, and...

CNH_Intelsat Annoucement_1920x1080CNH collaborates with Intelsat to provide ruggedized connectivity to farmers in remote locationsCNH expands network connectivity with Intelsat collaboration Field-ready connectivity option for hard-to-reach locations brings the power of precision agriculture to more CNH customers  Basildon, April 29, 2024 CNH (NYSE: CNHI) and Intelsat, operator of one of the world’s largest integrated satellite and terrestrial communication networks, today announced a collaboration that will be the first to provide farmers ubiquitous access to the internet via a ruggedized satellite communications (SATCOM) service. Based on a new memorandum of understanding, Intelsat will provide multi-orbit internet access to connect CNH equipment working in remote locations and easy-to-use satellite terminals ready to handle...

Boston (April 29, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that on April 27, 2024, it received formal notice from The Nasdaq Stock Market, LLC’s Office of General Counsel (“Nasdaq”). This notice confirmed that the Company has regained compliance with the minimum bid price requirement as set forth in Nasdaq’s Listing Rule 5550(a)(2) (the “Bid Price Rule”). Nasdaq noted that since April 9, 2024, Allarity’s stock has maintained a closing bid price above $1.00 per share for more than ten consecutive trading days, thereby meeting the requirements for regaining compliance. Thomas Jensen, CEO of Allarity Therapeutics, stated, “We are very pleased to announce NASDAQ’s confirmation of our...

SHANGHAI, China, April 29, 2024 (GLOBE NEWSWIRE) — ECARX Holdings, Inc. (Nasdaq: ECX) (“ECARX”), a global mobility tech provider, today announced that it will report its financial results for the first quarter of 2024 before the U.S. market opens on Monday, May 20, 2024. Company management will hold an earnings conference call via live audio webcast to discuss the financial results and will be available to answer questions from analysts and institutional investors. Earnings Conference Call & Webcast Details:Date: Monday, May 20, 2024Time: 8:00am ESTWebcast: https://edge.media-server.com/mmc/p/ji9r3h9b To join the live conference call, please register at https://register.vevent.com/register/BIeacb8a83827e45b4a0aa74556624b2c5 to receive the conference call details as well as international access numbers. Please join...

VANCOUVER, British Columbia, April 29, 2024 (GLOBE NEWSWIRE) — Liberty Gold Corp. (TSX:LGD; OTCQX:LGDTF) (“Liberty Gold” or the “Company”) is pleased to announce a non-brokered, private placement financing raising proceeds of up to C$9.50 million (the “Offering”). The Offering will consist of the issuance of up to 27,142,858 units of the Company (the “Units”) at an issue price of C$0.35 per Unit. Each Unit will consist of one common share of Liberty Gold (each, a “Common Share”) and 1/2 of a common share purchase warrant (a “Warrant”). Each Warrant will entitle the holder to acquire one common share of Liberty Gold at a price of C$0.45 for a period of 24 months following completion of the Offering. The proceeds of the Offering will be used for exploration drilling on seven high-priority target areas identified at Black Pine, engineering,...